Literature DB >> 35653419

Investigation of thiol-disulfide homeostasis and ischemia-modified albumin levels in patients with hidradenitis supurativa.

Zeynep Busra Balik1, Ahmet Rifat Balik2, Cigdem Yucel2, Yildiz Hayran3, Ercan Çaliskan1, Ozcan Erel4.   

Abstract

BACKGROUND: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease. The pathogenesis of HS is not clear, and the triggering mechanism for the initiation of the disease is still a controversy. AIMS: The present study aims to investigate the relationship between thiol-disulfide homeostasis (TDH), ischemia-modified albumin (IMA), and HS. To our knowledge, this will be the first report evaluating TDH and IMA status in HS. PATIENTS/
METHODS: The study included 30 patients with HS as the patient group and 30 healthy individuals as the control group. For determination of HS severity, Hurley and Hidradenitis suppurativa physician global assessment (PGA) scores were used. One tube venous blood specimen from every participant was obtained. IMA and TDH tests were analyzed in sera of participants. The results were evaluated statistically.
RESULTS: Disulfide (p < 0.001), Index I (p = 0.001), and Index II (p = 0.001) levels in HS group were significantly higher than control group. IMA levels in patients with higher Hurley scores are significantly higher (p = 0.032, r = 0.39). A positive correlation was observed between IMA level and disease duration (p = 0.021, r = 0.42).
CONCLUSIONS: The shift in thiol/disulfide balance toward disulfide and significant increase in IMA levels put out the importance of oxidation status in HS etiopathogenesis.
© 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  IMA; disulfide; hidradenitis suppurativa; oxidative stress; thiol

Year:  2022        PMID: 35653419     DOI: 10.1111/jocd.14753

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN: 1473-2130            Impact factor:   2.696


  1 in total

Review 1.  Ischemia-Modified Albumin-A Potential New Marker of Oxidative Stress in Dermatological Diseases.

Authors:  Mircea Tampa; Cristina Iulia Mitran; Madalina Irina Mitran; Andreea Amuzescu; Clara Matei; Simona Roxana Georgescu
Journal:  Medicina (Kaunas)       Date:  2022-05-17       Impact factor: 2.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.